Header cover image

Italian (Borsa Italiana) Pharma Industry Analysis

UpdatedDec 18, 2024
DataAggregated Company Financials
Companies3
  • 7D-0.9%
  • 3M0.8%
  • 1Y5.4%
  • YTD3.3%

Over the last 7 days, the Pharma industry has remained flat, although notably Friulchem gained 21%. The past year has been better, since the industry has gained 8.2% in that time. Looking forward, earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the Italian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 19 Dec 2024€10.4b€2.4b€428.8m16.8x24.3x4.4x
Sat, 16 Nov 2024€10.5b€2.4b€428.8m17x24.6x4.5x
Mon, 14 Oct 2024€10.8b€2.3b€392.7m17.4x27.5x4.7x
Wed, 11 Sep 2024€10.6b€2.3b€392.3m17.6x27x4.6x
Fri, 09 Aug 2024€10.1b€2.3b€392.3m16.8x25.7x4.4x
Sun, 07 Jul 2024€10.1b€2.2b€394.2m16.9x25.7x4.5x
Tue, 04 Jun 2024€10.0b€2.2b€394.2m16.8x25.4x4.5x
Thu, 02 May 2024€10.4b€2.2b€394.5m17.1x26.2x4.8x
Sat, 30 Mar 2024€10.6b€2.2b€395.0m17.2x26.8x4.9x
Mon, 26 Feb 2024€10.9b€2.1b€381.5m18.1x28.6x5.1x
Wed, 24 Jan 2024€10.4b€2.2b€384.6m27.2x27x4.8x
Fri, 22 Dec 2023€10.1b€2.2b€384.6m26.4x26.1x4.7x
Sun, 19 Nov 2023€9.5b€2.2b€384.6m24.8x24.6x4.4x
Tue, 17 Oct 2023€9.5b€2.1b€397.7m24.1x24x4.5x
Thu, 14 Sep 2023€9.5b€2.1b€395.8m43.5x24x4.5x
Sat, 12 Aug 2023€9.4b€2.1b€395.8m45.1x23.7x4.4x
Mon, 10 Jul 2023€8.7b€2.1b€346.9m20.5x25.1x4.1x
Wed, 07 Jun 2023€9.1b€2.1b€346.9m24x26.4x4.4x
Fri, 05 May 2023€8.5b€2.0b€319.7m23.9x26.7x4.3x
Sun, 02 Apr 2023€8.1b€2.0b€317.7m31x25.5x4.1x
Tue, 28 Feb 2023€8.3b€2.0b€317.8m31.1x26.2x4.3x
Thu, 26 Jan 2023€8.5b€1.9b€336.5m31.3x25.3x4.5x
Sat, 24 Dec 2022€8.1b€1.9b€336.5m29.6x24.1x4.3x
Mon, 21 Nov 2022€8.2b€1.9b€336.5m30.3x24.4x4.3x
Wed, 19 Oct 2022€7.7b€1.8b€336.4m22.4x22.8x4.2x
Fri, 16 Sep 2022€8.3b€1.8b€336.1m23.2x24.8x4.6x
Sun, 14 Aug 2022€8.8b€1.8b€336.1m24.9x26.1x4.9x
Tue, 12 Jul 2022€9.1b€1.7b€399.4m20.2x22.8x5.3x
Thu, 09 Jun 2022€8.2b€1.7b€399.8m18.9x20.4x4.8x
Sat, 07 May 2022€8.8b€1.7b€392.9m18.9x22.3x5.2x
Mon, 04 Apr 2022€9.6b€1.7b€392.0m21.9x24.4x5.7x
Wed, 02 Mar 2022€8.9b€1.6b€383.3m20.7x23.1x5.6x
Fri, 28 Jan 2022€10.3b€1.6b€383.3m23.6x26.9x6.5x
Sun, 26 Dec 2021€11.6b€1.6b€382.8m20x30.3x7.3x
Price to Earnings Ratio

30.3x


Total Market Cap: €11.6bTotal Earnings: €382.8mTotal Revenue: €1.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Italian Pharma Industry Price to Earnings3Y Average 25.3x202220232024
Current Industry PE
    There are only 3 companies in the Italian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.9% per year over the last three years.
  • Revenues for these companies have grown 14% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Italian Healthcare industry?

IT Market-0.40%
Healthcare-1.46%
Pharma-0.88%
Pharma-0.88%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRL Pierrel€1.750.6%
+€549.3k
-61.9%PE30.8x
SHE Shedir Pharma Group€4.880.4%
+€227.3k
7.5%PE9.2x
FCM Friulchem€0.890.6%
+€30.0k
-14.9%PS0.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.